Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

2.89
Delayed Data
As of 4:00pm ET
 +0.03 / +1.05%
Today’s Change
2.24
Today|||52-Week Range
5.28
-40.17%
Year-to-Date

Today’s Trading

Previous close2.86
Today’s open2.88
Day’s range2.85 - 2.93
Volume1,527,927
Average volume (3 months)636,308
Market cap$103.1M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-78.10%
Earnings growth (this year)+152.42%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.16%
P/E ratio1.8
Price/Sales3.37
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CPIXCumberland Pharmaceu...-0.01-0.14%
--EcoGreen Internation...0.000.00%
OTICOtonomy Inc+0.05+1.00%
BLRXBioLine RX Ltd+0.01+0.95%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$50.9M
Annual profit (last year)-$193.4M
Net profit margin-379.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Glenn P. Sblendorio
Chief Operating Officer &
Senior Vice President
Keith Westby
Corporate headquarters
New York, New York

Forecasts